Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1930 1
1952 1
1953 1
1956 1
1967 1
1968 1
1973 1
1976 1
1977 2
1980 1
1982 1
1983 1
1984 2
1985 2
1986 1
1987 1
1988 2
1989 1
1990 1
1991 4
1992 3
1993 5
1994 2
1995 8
1996 3
1997 3
1998 8
1999 5
2000 8
2001 7
2002 5
2003 7
2004 2
2005 6
2006 15
2007 15
2008 12
2009 8
2010 12
2011 14
2012 17
2013 18
2014 27
2015 21
2016 13
2017 16
2018 15
2019 18
2020 23
2021 24
2022 14
2023 16
2024 23
2025 17
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

418 results

Results by year

Filters applied: . Clear all
Page 1
Biomarkers in Post-kala-azar Dermal Leishmaniasis.
Zijlstra EE. Zijlstra EE. Front Cell Infect Microbiol. 2019 Jul 31;9:228. doi: 10.3389/fcimb.2019.00228. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31417876 Free PMC article. Review.
Post-kala-azar dermal leishmaniasis (PKDL) follows visceral leishmaniasis (VL, kala-azar) in 10-60% of cases. ...There is an extensive differential diagnosis, and parasitological confirmation is preferred particularly when drug treatme …
Post-kala-azar dermal leishmaniasis (PKDL) follows visceral leishmaniasis (VL, kala-azar) in 10-60 …
Post-Kala-Azar Dermal Leishmaniasis.
Sharma A, Bishnoi A, Parsad D. Sharma A, et al. Am J Trop Med Hyg. 2024 Jul 23;111(4):710-712. doi: 10.4269/ajtmh.24-0018. Print 2024 Oct 2. Am J Trop Med Hyg. 2024. PMID: 39043164 Free PMC article. No abstract available.
Post-kala-azar dermal leishmaniasis.
Pathania YS, Budania A. Pathania YS, et al. QJM. 2022 Jan 5;114(11):824-825. doi: 10.1093/qjmed/hcab236. QJM. 2022. PMID: 34499181 Free article. No abstract available.
Post-kala-azar dermal leishmaniasis.
Zijlstra EE, Musa AM, Khalil EA, el-Hassan IM, el-Hassan AM. Zijlstra EE, et al. Lancet Infect Dis. 2003 Feb;3(2):87-98. doi: 10.1016/s1473-3099(03)00517-6. Lancet Infect Dis. 2003. PMID: 12560194 Review.
Post-kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL); it is characterised by a macular, maculopapular, and nodular rash in a patient who has recovered from VL and who is otherwise well. ...Serologica …
Post-kala-azar dermal leishmaniasis (PKDL) is a complication of visceral leishmaniasis (VL); it is …
Epidemiology of Post-Kala-azar Dermal Leishmaniasis.
Ghosh P, Roy P, Chaudhuri SJ, Das NK. Ghosh P, et al. Indian J Dermatol. 2021 Jan-Feb;66(1):12-23. doi: 10.4103/ijd.IJD_651_20. Indian J Dermatol. 2021. PMID: 33911289 Free PMC article.
Post-kala-azar dermal leishmaniasis (PKDL) is a cutaneous sequel of visceral leishmaniasis (VL) or kala-azar and has become an entity of epidemiological significance by virtue of its ability to maintain the disease in circulation during i …
Post-kala-azar dermal leishmaniasis (PKDL) is a cutaneous sequel of visceral leishmaniasis (VL) or …
Post kala-azar dermal leishmaniasis in the Indian sub-continent: challenges and strategies for elimination.
Kumar A, Singh VK, Tiwari R, Madhukar P, Rajneesh, Kumar S, Gautam V, Engwerda C, Sundar S, Kumar R. Kumar A, et al. Front Immunol. 2023 Aug 11;14:1236952. doi: 10.3389/fimmu.2023.1236952. eCollection 2023. Front Immunol. 2023. PMID: 37638047 Free PMC article. Review.
Visceral leishmaniasis (VL) is a severe and often fatal form of leishmaniasis caused by Leishmania donovani in the Indian sub-continent. Post Kala-azar Dermal Leishmaniasis (PKDL) is a late cutaneous manifestation of VL, typically …
Visceral leishmaniasis (VL) is a severe and often fatal form of leishmaniasis caused by Leishmania donovani in the Indian sub- …
Post kala-azar dermal leishmaniasis: A threat to elimination program.
Gedda MR, Singh B, Kumar D, Singh AK, Madhukar P, Upadhyay S, Singh OP, Sundar S. Gedda MR, et al. PLoS Negl Trop Dis. 2020 Jul 2;14(7):e0008221. doi: 10.1371/journal.pntd.0008221. eCollection 2020 Jul. PLoS Negl Trop Dis. 2020. PMID: 32614818 Free PMC article. Review.
Leishmaniasis remains a public health concern around the world that primarily affects poor folks of the developing world spanning across 98 countries with mortality of 0.2 million to 0.4 million annually. Post kala-azar dermal leishmaniasis …
Leishmaniasis remains a public health concern around the world that primarily affects poor folks of the developing world spanning acr …
Immune Responses in Post Kala-azar Dermal Leishmaniasis.
Chatterjee M, Sengupta R, Mukhopadhyay D, Mukherjee S, Dighal A, Moulik S, Sengupta S. Chatterjee M, et al. Indian J Dermatol. 2020 Nov-Dec;65(6):452-460. doi: 10.4103/ijd.IJD_258_20. Indian J Dermatol. 2020. PMID: 33487699 Free PMC article.
Kala-azar, commonly known as visceral leishmaniasis (VL), is a neglected tropical disease that has been targeted in South Asia for elimination by 2020. Presently, the Kala-azar Elimination Programme is aimed at identifying new low-endemic foci by active case detection, con …
Kala-azar, commonly known as visceral leishmaniasis (VL), is a neglected tropical disease that has been targeted in South Asia for el …
Post-kala-azar dermal leishmaniasis: a global overview.
Ghosh C, Karmakar C, Sarkar D, Goswami D, Roy M, Sengupta S, Chaudhuri SJ, Roy S, Dutta B, Das A, Das NK, Chatterjee M. Ghosh C, et al. Clin Exp Dermatol. 2026 Apr 24;51(5):789-804. doi: 10.1093/ced/llag010. Clin Exp Dermatol. 2026. PMID: 41502015 Review.
Post-kala-azar dermal leishmaniasis (PKDL) is a chronic dermal sequela in apparently cured patients with visceral leishmaniasis (VL). ...The diagnosis of PKDL is challenging in macular cases due to their low parasite burden and ove …
Post-kala-azar dermal leishmaniasis (PKDL) is a chronic dermal sequela in apparently cured patient …
Post-kala-azar dermal leishmaniasis.
Ramesh V, Mukherjee A. Ramesh V, et al. Int J Dermatol. 1995 Feb;34(2):85-91. doi: 10.1111/j.1365-4362.1995.tb03584.x. Int J Dermatol. 1995. PMID: 7737782 Review. No abstract available.
418 results